Carlino, G., Fornaro, M., Santo, L., Bucci, R., Semeraro, A., Quarta, L., D’Onofrio, F., Marsico, A., Zuccaro, C., Falappone, P., Mazzotta, D., Cantatore, F., Muratore, M., & Iannone, F. (2019). Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE). Reumatismo, 71(1), 24-30.